1-19 of 19
Sara Tolaney
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2638: Sacituzumab Govitecan, combination with PARP inhibitor, Talazoparib, in metastatic triple-negative breast cancer (TNBC): Translational investigation

Aditya Bardia, James T. Coates, Laura Spring, Sheng Sun, Dejan Juric, Nayana Thimmiah, Andrzej Niemierko, Phoebe Ryan, Ann Partridge, Jeffrey Peppercorn, Heather Parsons, Seth Wander, Kelsey Pierce, Victoria Attaya, Donna Fitzgerald, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Bev Moy, Sara Tolaney, Leif Ellisen
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2638.
DOI: https://doi.org/10.1158/1538-7445.AM2022-2638
Published: 15 June 2022
View article
Journal Articles

Abstract 1773: Overcoming paclitaxel resistance in triple-negative breast cancer using a novel barcoding technology

Milos Spasic, Qiuchen Guo, Adam Maynard, Gregory Goreczny, Adrienne Waks, Sara Tolaney, Elizabeth Mittendorf, Sandra McAllister
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1773.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1773
Published: 15 June 2022
View article
Journal Articles

Abstract P5-13-15: High dimensional flow cytometric analysis or the peripheral immune profile and response to HER2-targeted antibody therapy

Esther R Ogayo, Adrienne Waks, Wade Rogers, Matei Ionita, Kenechukwu Adigwe, Jillian Alberti, Sapana Kadel, Jonni Moore, Tari King, Ian Krop, Sara Tolaney, Eric Winer, Jennifer Guerriero, Elizabeth Mittendorf
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-13-15.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P5-13-15
Published: 15 February 2022
View article
Journal Articles

Abstract P1-04-05: Multiplexed immunofluorescence staining of intra-tumoral immune cell populations and associations with immunohistochemical, clinical, and pathologic variables in breast cancer

Tess A. O'Meara, Tanya E. Keenan, Adrienne G. Waks, Kristen D. Felt, Bijaya Sharma, Scott Rodig, Melissa Hughes, Nancy U. Lin, Judith Agudo, Jennifer L. Guerriero, Sandra S. McAllister, Elizabeth Mittendorf, Sara Tolaney
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-04-05.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-04-05
Published: 15 February 2022
View article
Journal Articles

Abstract P1-04-13: Generation and validation of an estrogen receptor signaling (ERS) gene panel that inversely correlates with antigen presentation and T cell infiltration and activity in hormone receptor positive (HR+) breast cancer

Jonathan S Goldberg, Xiaoyong Cui, Kenichi Shimada, Sandra McAllister, Sara Tolaney, Adrienne Waks, Rinath Jeselsohn, Jennifer Guerriero, Judith Agudo, Elizabeth Mittendorf
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-04-13.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-04-13
Published: 15 February 2022
View article
Journal Articles

Abstract PS9-40: Multiple activities improve oncologists' knowledge and competence with CDK4/6 inhibitors in HR+ breast cancer over time

Kinjal Parikh, Nabil Dorkhom, Pan Chen, Davecia Ragoonath Cameron, Mindy Tanzola, Pamela Peters, Sara Tolaney
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS9-40.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS9-40
Published: 15 February 2021
View article
Journal Articles

Abstract GS4-01: Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane

Joyce O'Shaughnessy, Lee Schwartzberg, Martine Piccart, Hope S. Rugo, Denise A Yardley, Javier Cortes, Michael Untch, Nadia Harbeck, Gail S. Wright, Igor Bondarenko, John Glaspy, Zbigniew Nowecki, Fadi Kayali, Arlene Chan, Christelle Levy, Mei-Ching Liu, Sung-Bae Kim, Julie Lemieux, Alexey Manikhas, Sara Tolaney, Elaine Lim, Andrea Gombos, Agostina Stradella, Mark Pegram, Peter Fasching, Laszlo Mangel, Vladimir Semiglazov, Veronique Dieras, Luca Gianni, Michael A Danso, Jeff Vacirca, Stew Kroll, Joseph O'Connell, Kevin Tang, Thomas Wei, Andrew Seidman
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): GS4-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-GS4-01
Published: 15 February 2021
View article
Journal Articles

Abstract OT-03-08: A Phase 2, open-label study to evaluate the safety and efficacy of the probody therapeutic (Pb-Tx) CX-2009 in metastatic HR-Positive/HER2-negative breast cancer (mHR+/HER2− BC) and of CX-2009 as monotherapy and in combination therapy with CX-072 in metastatic triple-negative breast cancer (TNBC)

Kathy D. Miller, Leisha A. Emens, Sara Tolaney, Sara A. Hurvitz, Erika Hamilton, Virginia Paton, Alison Hannah, Valentina Boni
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): OT-03-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-OT-03-08
Published: 15 February 2021
View article
Journal Articles

Abstract OT-09-09: AMEERA-3, a phase 2 trial of SAR439859 vs endocrine monotherapy in pre- and post-menopausal, estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (her2−), locally advanced or metastatic breast cancer (BC) with prior exposure to hormonal therapies

Sara Tolaney, Irfan Cicin, Rafael Betancourt, Arlene Chan, Diego Kaen, Peter Kaufman, Suzette Delaloge, Qianying Liu, Sylvaine Cartot-Cotton, Amele Amrate, Vasiliki Pelekanou, Katharine Cuff
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): OT-09-09.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-OT-09-09
Published: 15 February 2021
View article
Journal Articles

Abstract OT-33-01: Combination ipatasertib and atezolizumab to prevent recurrence in triple negative breast cancer(TNBC): A phase II single arm trial

Elizabeth Mittendorf, Sara Tolaney, Paul Wileyto, Michelle DeMeo, Hope Rugo, Rita Nanda, Ingrid Mayer, Ben Park, Heather MacArthur, Angela DeMichelle
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): OT-33-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-OT-33-01
Published: 15 February 2021
View article
Journal Articles

Abstract PS4-25: Comprehensive genomic analysis reveals molecular correlates of response to immune checkpoint inhibitors (ICI) in metastatic triple-negative breast cancer (mTNBC)

Romualdo Barroso-Sousa, Juliet Forman, Zachary T. Weber, Katherine Collier, Katrina Z. Kao, Edward T. Richardson, III, Tanya Keenan, Ofir Cohen, Michael P. Manos, Ryan C. Brennick, Patrick Ott, F. Steve Hodi, Deborah A. Dillon, Nancy U. Lin, Eliezer E. Van Allen, Scott Rodig, Eric P. Winer, Elizabeth A. Mittendorf, Catherine J. Wu, Daniel Stover, Nikhil Wagle, Sachet Shukla, Sara Tolaney
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS4-25.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS4-25
Published: 15 February 2021
View article
Journal Articles

Abstract OT2-04-02: CheckMate 7A8: A phase 2 trial of nivolumab + abemaciclib or palbociclib + anastrozole in postmenopausal women with ER+, HER2−primary breast cancer

Sara Tolaney, Guy Jerusalem, Roberto Salgado, Xiaochun Liu, Tian Chen, Hongxia Zhang, Mustimbo Roberts, Dimitrios Zardavas, Aleix Prat
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT2-04-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-OT2-04-02
Published: 15 February 2020
View article
Journal Articles

Abstract OT1-08-08: CONTESSA TRIO: A multinational, multicenter, phase 2 study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with HER2- metastatic breast cancer (MBC)

Sara Tolaney, Joanne Blum, Igor Bondarenko, Arlene Chan, Noshir DaCosta, Yin-Hsun Feng, Yann Izarzugaza, Sung-Bae Kim, Mei-Ching Liu, Maria Eva Peréz Lopéz, Mafalda Oliveira, Samuel Guan Wei Ow, Michel Pavic, Hope Rugo, Lee Schwartzberg, Agostina Stradella, Stew Kroll, Joseph O'Connell, Thomas Wei, Elizabeth Mittendorf
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT1-08-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-OT1-08-08
Published: 15 February 2020
View article
Journal Articles

Abstract P1-15-05: Identifying educational needs and areas for improvement in the management of HR+, HER2- breast cancer using cyclin-dependent kinase 4/6 inhibitors

Sara Tolaney, Joyce A. O'Shaughnessy, Rebecca Crawford, Tariqa Ackbarali, Laurence Greene, Jeffrey Carter, Tamar Sapir
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P1-15-05.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P1-15-05
Published: 15 February 2020
View article
Journal Articles

Abstract PD10-02: Patient reported outcomes from the adjuvant trastuzumab emtansine (T-DM1) vs. paclitaxel + trastuzumab (TH) (ATEMPT) trial (TBCRC 033)

Ann Partridge, Yue Zheng, Shoshana Rosenberg, Richard Gelber, Shari Gelber, William Barry, Chau Dang, Denise Yardley, Steven Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Douglas Weckstein, Antonio Wolff, Katherine Reeder-Hayes, Hope Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Schneider, Merrill Garrett, P. Kelly Marcom, Kathy Albain, Patricia Defusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel Jankowitz, Michelle DeMeo, Harold Burstein, Eric P. Winer, Ian Krop, Sara Tolaney
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD10-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-PD10-02
Published: 15 February 2020
View article
Journal Articles

Abstract CT050: Expansion cohort of Phase I study of oral sapacitabine and oral seliciclib in patients with metastatic breast cancer and BRCA1/2 mutations

Tanya Keenan, David Liu, Haitham Elmarakeby, Daniel Stover, Bose Kochupurakkal, Adam Tracy, Elaine Danielczyk, Leilani Anderson, Chelsea Andrews, Brendan Reardon, Beth Overmoyer, Eric Winer, Daniella Zheleva, Judy Chiao, David Blake, Eliezer Van Allen, Geoffrey I. Shapiro, Sara Tolaney
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT050.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT050
Published: 01 July 2019
View article
Journal Articles

Abstract 2918: Analysis of matched pre and post cisplatin-treated muscle-invasive bladder cancer reveals a candidate cisplatin mutational signature

David Liu, Daniel Keliher, Philip Abbosh, Kent Mouw, Diana Miao, Mariel Boyd, Jean Hoffman-Censits, Gopa Iyer, Sara Tolaney, Jaegil Kim, Gad Getz, Scott Carter, Joaquim Bellmunt, Elizabeth R. Plimack, Jonathan E. Rosenberg, Eliezer M. Van Allen
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2918.
DOI: https://doi.org/10.1158/1538-7445.AM2017-2918
Published: 01 July 2017
View article
Journal Articles

Abstract 2986: Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses

Peter Schmid, Cristina Cruz, Fadi S. Braiteh, Joseph Paul Eder, Sara Tolaney, Irene Kuter, Rita Nanda, Cathie Chung, Philippe Cassier, Jean-Pierre Delord, Michael Gordon, Yijin Li, Bo Liu, Carol O’Hear, Marcella Fasso, Luciana Molinero, Leisha A. Emens
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2986.
DOI: https://doi.org/10.1158/1538-7445.AM2017-2986
Published: 01 July 2017
View article
Journal Articles

Abstract P3-04-01: Whole transcriptome analysis of AR+ ER/PR- metastatic breast cancers treated with bicalutamide on TBCRC011

Tiffany A Traina, Ayca Gucalp, William Polkinghorn, Steven Isakoff, Sara Tolaney, Lisa Carey, James Ingle, Lisle Nabell, Andres Forero, Hope Rugo, Kimberly Blackwell, Minetta Liu, Matthew Soloway, Lisle Mose, Dilip Giri, Agnes Viale, Clifford Hudis, Charles Sawyers, Joel Parker
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P3-04-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-P3-04-01
Published: 01 May 2015
View article